269 related articles for article (PubMed ID: 21265402)
1. Blood conservation in cardiac surgery.
Anderson L
J Perioper Pract; 2010 Dec; 20(12):436-9. PubMed ID: 21265402
[TBL] [Abstract][Full Text] [Related]
2. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators.
Laupacis A; Fergusson D
Anesth Analg; 1997 Dec; 85(6):1258-67. PubMed ID: 9390590
[TBL] [Abstract][Full Text] [Related]
3. The use of technologies to decrease peri-operative allogenic blood transfusion: results of practice variation in Israel.
Katz E; Gaitini L; Samri M; Egoz N; Fergusson D; Laupacis A
Isr Med Assoc J; 2001 Nov; 3(11):809-12. PubMed ID: 11729574
[TBL] [Abstract][Full Text] [Related]
4. [The "Seville" Consensus Document on Alternatives to Allogenic Blood Transfusion. Sociedades españolas de Anestesiología (SEDAR), Medicina Intensiva (SEMICYUC), Hematología y Hemoterapia (AEHH), Transfusión sanguínea (SETS) Trombosis y Hemostasia (SETH)].
Alberca I; Asuero MS; Bóveda JL; Carpio N; Contreras E; Fernández-Mondéjar E; Forteza A; García-Erce JA; García de Lorenzo A; Gomar C; Gómez A; Llau JV; López-Fernández MF; Moral V; Muñoz M; Páramo JA; Torrabadella P; Quintana M; Sánchez C
Med Clin (Barc); 2006 Jul; 127 Suppl 1():3-20. PubMed ID: 17020674
[TBL] [Abstract][Full Text] [Related]
5. Strategies for minimizing blood loss in orthopedic surgery.
Tobias JD
Semin Hematol; 2004 Jan; 41(1 Suppl 1):145-56. PubMed ID: 14872436
[TBL] [Abstract][Full Text] [Related]
6. Perioperative blood conservation.
Cardone D; Klein AA
Eur J Anaesthesiol; 2009 Sep; 26(9):722-9. PubMed ID: 19448549
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
Levi M; Cromheecke ME; de Jonge E; Prins MH; de Mol BJ; Briët E; Büller HR
Lancet; 1999 Dec; 354(9194):1940-7. PubMed ID: 10622296
[TBL] [Abstract][Full Text] [Related]
8. Hemostatic drugs.
Mannucci PM
N Engl J Med; 1998 Jul; 339(4):245-53. PubMed ID: 9673304
[No Abstract] [Full Text] [Related]
9. Perioperative systemic haemostatic agents.
Mahdy AM; Webster NR
Br J Anaesth; 2004 Dec; 93(6):842-58. PubMed ID: 15277296
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological approaches to reducing blood loss and transfusions in the surgical patient.
Ozier Y; Schlumberger S
Can J Anaesth; 2006 Jun; 53(6 Suppl):S21-9. PubMed ID: 16766788
[TBL] [Abstract][Full Text] [Related]
11. [Drugs to reduce transfusion needs during surgery].
Pleym H
Tidsskr Nor Laegeforen; 2008 Apr; 128(7):829-30. PubMed ID: 18389031
[TBL] [Abstract][Full Text] [Related]
12. Pro: tranexamic acid is better than aprotinin in decreasing bleeding after cardiac surgery.
Guenther CR
J Cardiothorac Vasc Anesth; 1994 Aug; 8(4):471-3. PubMed ID: 7524719
[No Abstract] [Full Text] [Related]
13. [Perioperative blood loss--the role of the anesthetist].
Booke M; Mertes N; Wüllenweber J; Van Aken H
Dtsch Med Wochenschr; 1998 Apr; 123(18):569-72. PubMed ID: 9615697
[No Abstract] [Full Text] [Related]
14. Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest.
Sniecinski RM; Chen EP; Makadia SS; Kikura M; Bolliger D; Tanaka KA
J Cardiothorac Vasc Anesth; 2010 Dec; 24(6):959-63. PubMed ID: 20430647
[TBL] [Abstract][Full Text] [Related]
15. Con: tranexamic acid is not better than aprotinin in decreasing bleeding after cardiac surgery.
Murkin JM
J Cardiothorac Vasc Anesth; 1994 Aug; 8(4):474-6. PubMed ID: 7524720
[No Abstract] [Full Text] [Related]
16. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological alternatives to blood transfusion: what is new about?].
Páramo JA; Lecumberri R; Hernández M; Rocha E
Med Clin (Barc); 2004 Feb; 122(6):231-6. PubMed ID: 15012894
[TBL] [Abstract][Full Text] [Related]
18. [Hemostatic drugs in a patient with antiphospholipid syndrome and clinically significant perioperative bleeding].
Martínez Rodríguez E; Mato M; Otero J; Ferri JR; Gonzálvez A; Torres LM
Rev Esp Anestesiol Reanim; 2006 Mar; 53(3):195-7. PubMed ID: 16671265
[No Abstract] [Full Text] [Related]
19. Current status of non-transfusional haemostatic agents.
Cattaneo M; Mannucci PM
Haematologica; 1999 Jun; 84 Suppl EHA-4():120-3. PubMed ID: 10907488
[No Abstract] [Full Text] [Related]
20. Bloodless cardiac surgery: not just possible, but preferable.
Putney LJ
Crit Care Nurs Q; 2007; 30(3):263-70. PubMed ID: 17579310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
